We now expect the delighting Krispy Kreme fans with our melting of mouth doughnuts fresh daily in nearly 2,000 McDonald’s restaurants by the end of 2024.
— Josh Charlesworth
03Detailed Report
DNUT
Company DNUT
Period
Q3 2024
CurrencyUSD
Report TypeQuarterly Earnings
GeneratedJun 27, 2026
Swipe to view all report sections
Executive Summary
Krispy Kreme reported Q3 2024 net revenue of $379.9 million, down 6.75% year over year and 13.4% quarter over quarter, largely reflecting the July 2024 completion of the Insomnia Cookies divestiture and the seasonality of the period. Organic growth was 3.5% for the quarter, marking the 17th consecutive quarter of organic growth, driven by a 15% rise in Delivered Fresh Daily (DFD) and digital channels. The company disclosed a substantial strategic pivot toward a capital-light international footprint and a rapid U.S. expansion through McDonald’s, with the goal of making Krispy Kreme doughnuts available in roughly 12,000 McDonald’s locations by end-2026 and up to ~35,000 points of access globally within three years. Management highlighted the potential for $340–$430 million in annualized incremental revenue and $70–$100 million in incremental Adjusted EBITDA from the U.S. DFD initiative. In the near term, EBITDA margin compressed to 9.1% for the company as a whole, pressured by Insomnia Cookies divestiture-related effects, UK underperformance, and start-up costs associated with the McDonald’s rollout. Net income was $39.6 million, supported by $71.3 million of other income and a net positive contribution from the Insomnia Cookies transaction (net proceeds of $117.6 million and a $45 million loan repayment). The balance sheet shows meaningful leverage relief to about 3.9x post-divestiture, with liquidity modest (cash ~$25.9 million) and a plan to realize $8–$12 million of annualized SG&A savings beginning in 2025. The Q3 results set the stage for a sharper margin recovery in 2025 as U.S. DFD scale and hub-and-spoke efficiency drive operating leverage, offset by near-term start-up costs. Investors should monitor DFD execution, UK market recovery, and the timing of gross-margin expansion as manufacturing upgrades and route-density improvements mature.
Balance sheet and liquidity:
- Total assets: $3.066 billion; Total liabilities: $1.856 billion; Total equity: $1.180 billion
- Cash and cash equivalents: $25.9 million; Net debt: $1.279 billion; Leverage (net debt/EBITDA): ~3.9x
- Long-term debt (gross): $1.211 billion; Debt to capital: 0.525; Debt to equity: 1.106
Cash flow and capital allocation:
- Operating cash flow: $3.26 million year-to-date; Free cash flow: -$22.88 million
- Capital expenditures: $26.14 million; Investing cash flow negative after hub investments
- Divestiture proceeds: Insomnia Cookies sale net proceeds $117.6 million; loan repayment $45 million
Segment performance (Q3 2024):
- U.S. organic revenue growth: 2.5%; Adjusted EBITDA: $13.9 million; EBITDA margin down 6.1%
- International organic revenue growth: 4.2%; Adjusted EBITDA margin 17.4%; UK underperformance noted
- Market Development (capital-light franchise model): Organic revenue growth 8.6%; Adjusted EBITDA margin 54.2%
Guidance snapshot (full year 2024):
- Revenue: $1.65–$1.685 billion; Organic growth: 5%–7%
- Adjusted EBITDA: $205–$210 million
- Adjusted EPS: $0.18–$0.22
- SG&A efficiency: $8–$12 million annualized savings beginning in 2025
Income Statement
Metric
Value
YoY Change
QoQ Change
Revenue
379.87M
-6.75%
-13.43%
Gross Profit
284.03M
-7.18%
238.70%
Operating Income
-16.00M
-657.41%
-284.44%
Net Income
39.56M
197.79%
820.51%
EPS
0.23
195.83%
807.69%
Key Financial Ratios
Gross Profit Margin
Excellent
74.80%
Gross profit margin is exceptional, indicating strong pricing power and operational efficiency
Operating Profit Margin
Weak
-0.04%
Operating margin is below industry norms, profitability concerns
Net Profit Margin
Good
10.40%
Net profit margin is healthy and competitive within industry standards
Return on Assets
Weak
1.29%
Return on assets suggests inefficient capital allocation
Return on Equity
Weak
3.35%
Return on equity suggests inefficient capital allocation
Current Ratio
Concern
0.35
Current ratio below safe levels, potential liquidity risk
Debt to Equity
High Risk
1.11
Debt-to-equity indicates high leverage and elevated financial risk
P/E Ratio
Value
11.51x
P/E ratio suggests potential undervaluation or stable earnings
Price to Book
Fair Value
1.54x
Price-to-book ratio reasonable for profitable companies
Management Insights Available for Members
Get exclusive access to management commentary, earnings call quotes, and forward guidance from company leadership.